NMS in PD: Dopaminergic and Nondopaminergic

Article Figures & Data

Figures

  • Figure 1.

    Effects of Ropinirole on Sleep Quality in Patients With PD

    AMTD=adjusted mean treatment difference; LOCF=last observation carried forward; OC=observed case; PDSS=Parkinson's Disease Sleep Scale.Reproduced with permission from John Wiley and Sons from Chaudhuri KR, Martinez-Martin P, Rolfe KA, et al. Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease. Eur J Neurol 2012;19:105–115.*On November 21, 2014, this was corrected from 0.005 to 0.0306.
  • Figure 2.

    Pimavanserin Reduces Psychosis Severity in Patients With PD

    PD=Parkinson's disease; SAPS-PD=Scale for Assessment of Positive Symptoms, Adapted for Parkinson's Disease.Reproduced with permission from Elsevier from Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 2014;383:533–540.